Gene · 4082
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. | J Biomed Sci | 2021 | 33849537 | PubTator, text mining | PubMed |
| Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways. | Int J Oncol | 2021 | 33846781 | PubTator, text mining | PubMed |
| Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | Nature | 2021 | 33845483 | PubTator, text mining | PubMed |
| Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer. | Front Oncol | 2021 | 33842315 | PubTator, text mining | PubMed |
| Centrosome-mediated microtubule remodeling during axon formation in human iPSC-derived neurons. | EMBO J | 2021 | 33835529 | PubTator, text mining | PubMed |
| Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. | Mol Psychiatry | 2021 | 33828235 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analyses Define Distinct Peripheral B Cell Subsets and Discrete Development Pathways. | Front Immunol | 2021 | 33815362 | PubTator, text mining | PubMed |
| Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells. | Cells | 2021 | 33802801 | PubTator, text mining | PubMed |
| Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. | Cancers (Basel) | 2021 | 33802238 | PubTator, text mining | PubMed |
| Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models. | Int J Mol Sci | 2021 | 33802212 | PubTator, text mining | PubMed |
| The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma. | Cancers (Basel) | 2021 | 33799793 | PubTator, text mining | PubMed |
| Creation and Validation of a Novel Sex-Specific Mortality Risk Score in LVAD Recipients. | J Am Heart Assoc | 2021 | 33764158 | PubTator, text mining | PubMed |
| MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer. | Theranostics | 2021 | 33754052 | PubTator, text mining | PubMed |
| Critical role of lipid membranes in polarization and migration of cells: a biophysical view. | Biophys Rev | 2021 | 33747247 | PubTator, text mining | PubMed |
| Exosomal Long Non-coding RNAs: Emerging Players in the Tumor Microenvironment. | Mol Ther Nucleic Acids | 2021 | 33738133 | PubTator, text mining | PubMed |
| MARCKS affects cell motility and response to BTK inhibitors in CLL. | Blood | 2021 | 33735912 | PubTator, text mining | PubMed |
| Protein N-myristoylation: functions and mechanisms in control of innate immunity. | Cell Mol Immunol | 2021 | 33731917 | PubTator, text mining | PubMed |
| Targeting the AXL Receptor in Combating Smoking-related Pulmonary Fibrosis. | Am J Respir Cell Mol Biol | 2021 | 33730527 | PubTator, text mining | PubMed |
| High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7. | Onco Targets Ther | 2021 | 33727826 | PubTator, text mining | PubMed |
Transcriptional profiling of the response to the trichloroethylene metabolite S-(1,2-dichlorovinyl)-L-cysteine revealed activation of the eIF2α/ATF4 integrated stress response in two in vitro placental models. | Arch Toxicol | 2021 | 33725128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4082/papers?page=32